Synthesis Capital

www.synthesis.capital

VCMatch tracks Synthesis Capital as an investor focused on Biotech, Foodtech, and Agtech companies, Seed and Series A rounds, Global, United States, and United Kingdom markets, and $300m check sizes. Upload your deck to compare your startup against the full private matching profile.

Check Size

$300m

Stages

Seed, Series A, Series B, Series C

Focus Areas

Biotech, Foodtech, Agtech

Geography

global, United States, and United Kingdom

Investment Thesis

This firm invests in platform-scale food technologies that can re‑engineer how food is made, scaled and consumed — prioritising systems-level change over isolated product bets. They combine domain expertise (investors, founders, scientists) with hands‑on operational support to de‑risk and scale category‑leading companies across biology and non‑biological enabling technologies. Sustainability and commercial returns are treated as mutually reinforcing outcomes.

Is Synthesis Capital right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Synthesis Capital is most relevant for founders raising Seed, Series A, and Series B rounds in Biotech, Foodtech, Agtech, and AI/ML, especially across global, United States, and United Kingdom, with public check-size signals around $300m.

Focus statement

They back category‑leading, platform technologies across the food system (biomanufacturing, plant and alternative proteins, feedstock & ingredient platforms, novel fats/oils, waste‑to‑feedstock) primarily at Series A–C (with seed activity) from a $300M+ food technology fund, investing in enabling technologies that unlock scale, taste, nutrition and cost reductions.

Value Add

System‑level investment thesis: explicitly 'We invest in systems, not silos.' — they target technologies that connect across the food value chain so progress compounds across multiple areas.
Sector depth: a global team of investors, founders and scientists with decades of foodtech/biotech experience and advisors who have 'shaped industries.'
Hands‑on, founder partnership model: repeated examples show close operational engagement (e.g., led Seed/Series A investments, go‑to‑market and scale‑up advice, strategic introductions).
Dedicated capital: a stated '$300M+ food technology fund' focused on leading investments from Series A to C.
Platform emphasis: preference for 'platform technologies' (biological and non‑biological) that enable downstream products and scalable manufacturing.
Track record/examples: portfolio companies exemplify thesis (Equinom, Hyfé, Redefine Meat, Savor, Perfect Day, Upside Foods, etc.), demonstrating investments across plant protein, biomanufacturing, novel fats, and waste conversion.